Direct-To-Consumer Teledermatology Growth: A Review And Outlook For The Future

The direct-to-consumer (DTC) telemedicine industry, including teledermatology, has seen rapid growth in recent years, partly due to the COVID-19 pandemic. The shortage of dermatologists and the visual nature of dermatologic conditions have attracted DTC companies to dermatology. However, there are concerns about conflicts of interest, overdiagnosis, and overprescribing associated with DTC teledermatology. The DTC model offers greater autonomy and convenience for patients, but it may impact the quality of care and the nature of physician-patient relationships. The DTC model of care is fundamentally different from traditional care models as it changes the roles of the patient and physician. Despite its shortcomings, DTC teledermatology is here to stay, and understanding this industry will allow dermatologists to advise patients and advocate for best practices.